We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
New Oriental
EDU
$8.84B
| $9.01M | 0.01% |
+163,714
| New | +$8.98M |
|
1027
PUT
CVS Health
CVS
$120B
| $8.98M | 0.01% |
113,100
-279,000
| -71% | -$22M |
|
|
VRE
1028
DELISTED
Veris Residential
VRE
| $8.97M | 0.01% |
+602,663
| New | +$8.9M |
|
|
STLN
1029
Starling Oncology, Inc. Common Stock
STLN
$632M
| $8.97M | 0.01% |
2,518,437
+100
| +0% | +$371 |
|
|
PLYM
1030
DELISTED
Plymouth Industrial REIT
PLYM
| $8.92M | 0.01% |
407,779
-154,480
| -27% | -$3.39M |
|
1031
Workday
WDAY
$44.8B
| $8.91M | 0.01% |
41,501
+23,761
| +134% | +$5.4M |
|
1032
PUT
AbbVie
ABBV
$442B
| $8.91M | 0.01% |
39,000
-60,400
| -61% | -$13.8M |
|
1033
PUT
Teva Pharmaceuticals
TEVA
$42.5B
| $8.91M | 0.01% |
285,500
+265,300
| +1,313% | +$6.54M |
|
1034
Cousins Properties
CUZ
$4.83B
| $8.89M | 0.01% |
344,908
-560,923
| -62% | -$14.6M |
|
1035
PUT
iShares US Real Estate ETF
IYR
$4.48B
| $8.87M | 0.01% |
+94,500
| New | +$9.01M |
|
1036
PUT
Maplebear
CART
$11.4B
| $8.87M | 0.01% |
197,200
+141,600
| +255% | +$5.8M |
|
1037
Tenaris
TS
$27B
| $8.8M | 0.01% |
+228,960
| New | +$8.83M |
|
1038
CALL
PayPal
PYPL
$50.5B
| $8.8M | 0.01% |
150,700
-130,800
| -46% | -$8.49M |
|
1039
Four Corners Property Trust
FCPT
$2.69B
| $8.79M | 0.01% |
381,391
-1,037,715
| -73% | -$24.7M |
|
1040
PUT
Okta
OKTA
$26.1B
| $8.79M | 0.01% |
101,600
+69,700
| +218% | +$6.08M |
|
1041
CALL
Lyft
LYFT
$6.64B
| $8.78M | 0.01% |
453,500
-49,000
| -10% | -$1.02M |
|
1042
Benitec Biopharma
BNTC
$463M
| $8.78M | 0.01% |
+651,558
| New | +$9.01M |
|
1043
CALL
Palo Alto Networks
PANW
$313B
| $8.75M | 0.01% |
47,500
-3,500
| -7% | -$706K |
|
1044
Molina Healthcare
MOH
$10.2B
| $8.75M | 0.01% |
50,392
-11,510
| -19% | -$1.89M |
|
1045
Papa John's
PZZA
$801M
| $8.73M | 0.01% |
+226,782
| New | +$10M |
|
|
DVAX
1046
DELISTED
Dynavax Technologies
DVAX
| $8.73M | 0.01% |
+567,389
| New | +$6.25M |
|
1047
Verizon
VZ
$196B
| $8.72M | 0.01% |
214,076
+100,814
| +89% | +$4.09M |
|
1048
CALL
Strategy Inc
MSTR
$37.8B
| $8.71M | 0.01% |
57,300
+31,500
| +122% | +$7.25M |
|
|
ECHO
1049
CALL
EchoStar
ECHO
$25.6B
| $8.7M | 0.01% |
80,000
-1,500
| -2% | -$122K |
|
1050
Amneal Pharmaceuticals
AMRX
$5.46B
| $8.69M | 0.01% |
689,867
+43,681
| +7% | +$500K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.